Image

Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR

Studying Inflammation in Parkinson's Disease with Brain Imaging

Recruiting
50-85 years
All
Phase N/A

This study investigates inflammation in Parkinson's disease using special imaging techniques. The purpose is to understand how inflammation occurs and its mechanisms in Parkinson's disease. Participants will be in the study for about two visits. During these visits, they will have special brain scans called PET scans, which use a tracer to highlight inflammation areas in the brain. A compound called LPS will be given to cause a mild inflammation, and blood samples will be taken to measure inflammation levels.

Participants will undergo two visits, starting with a clinical examination and tests on memory and movement. They will have an MRI scan to take pictures of the brain. In the second visit, they will have two PET scans, one before and one after receiving LPS. Blood pressure and heart rate will be monitored after LPS is given. The study will include two blood draws to check inflammation levels.

  • Who can participate: Participants should be 50-85 years old, able to give consent, and have good vision and hearing. They must not have major neurological or psychiatric disorders or a history of inflammatory or autoimmune diseases.
  • Study details: Participants will attend two visits for PET scans, MRI scans, and blood tests. LPS will be given to study inflammation effects, with safety monitoring during the study.
  • Study visits: The study requires 2 visits.
Study details
    Neurodegenerative Diseases
    Parkinson Disease
    REM Sleep Behavior Disorder (iRBD)

NCT05205291

University of Exeter

8 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.